Search

A study conducted in Xi'an, People's Republic of China, evaluated the feasibility and safety of ultrasound-guided radiofrequency ablation for treating papillary thyroid microcarcinoma. The study included fifty patients who had undergone this treatment. The results showed a gradual decrease in the volume of the ablation area over time, with no significant difference in thyroid function before and after treatment. The most common complication was slight pain in the neck, which subsided within 24 hours. The study concluded that ultrasound-guided radiofrequency ablation is a safe and effective surgical option for treating this type of thyroid cancer while preserving thyroid function. [Extracted from the article]